ArticleACS medicinal chemistry letters2026

Novel Tricyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.

Ram W Sabnis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.